References
- LiYHuangGDiakurJWiebeLITargeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug developmentCurr Drug Deliv20085429930218855599
- MorellAGIrvineRASternliebIScheinbergIHAshwellGPhysical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivoJ Biol Chem196824311551595635941
- HuZHLiuYZhangLPreparation of a novel liver-targeting nanoparticle of norcantharidin derivative and evaluation of its antitumor activityJ Exp Nanosci201162183199
- ChewJLWolfowiczCBMaoHQLeongKWChuaKYChitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in miceVaccine20032121–222720272912798609
- WuYYangWLWangCCHuJHFuSKChitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinateInt J Pharm20052951–223524515848008
- AmidiMMastrobattistaEJiskootWHenninkWEChitosan-based delivery systems for protein therapeutics and antigensAdv Drug Delivery Rev20106215982
- YamashitaSTanakaYEndohYAnalysis of drug permeation across Caco-2 monolayer: implication for predicting in vivo drug absorptionPharm Res19971444864919144736
- CalvoPRemunan-LópezCVila-JatoJLAlonsoMJChitosan and chitosan/ethylene oxide-propylene oxide block copolymer NPs as novel carriers for proteins and vaccinesPharm Res19971410143114369358557
- YangZQXuJPanPZhangXNPreparation of an alternative freeze-dried PH-sensitive cyclosporine A nanoparticle formulation and its pharmacokinetic profile in ratsPharmazie2009641263119216227
- BradfordMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye bindingAnal Biochem197672248254942051
- HuangMMaZKhorELimLYUptake of FITC-chitosan nanoparticles by A549 cellsPharm Res20021911488149412425466
- HuMChenJZhuYDantzigAHStratfordREJrKuhfeldMTMechanism and kinetics of transcellular transport of a new beta-lactam antibiotic loracarbef across an intestinal epithelial membrane model system (Caco-2)Pharm Res19941110140514137855043
- SunHPangKSPermeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical studyDrug Metab Dispos200836110212317932224
- RezaMSQuadirMAHaiderSSComparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug deliveryJ Pharm Pharm Sci20036228229112935440
- Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Delivery Rev2004561116491659
- MeschiniSMolinariACalcabriniACitroGAranciaGIntracellular localization of the antitumour drug adriamycin in living cultured cells: a confocal microscopy studyJ Micros1994176Pt 3204210
- KotzéAFLuessenHLde LeeuwBJde BoerAGVerhoefJCJungingerHEComparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2)J Control Release199851135469685902
- ArturssonPPalmKLuthmanKCaco-2 monolayers in experimental and theoretical predictions of drug transportAdv Drug Deliv Rev2001461–3274311259831
- DantzigAHHoskinsJATabasLBAssociation of intestinal peptide transport with a protein related to the cadherin superfamilyScience199426451574304338153632
- KoolMde HaasMSchefferGLAnalysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell linesCancer Res19975716353735479270026
- van der SandtICBlom-RoosemalenMCde BoerAGBreimerDDSpecif icity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell linesEur J Pharm Sci200011320721411042226
- ArturssonPKarlssonJCorrelation between oral drug absorption in humans and drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochem Biophys Res Commun199917538808851673839
- NakagamiTYasui-FurukoriNSaitoMTateishiTKaneoSEffect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone dispositionClin Pharmacol Ther2005781435116003291
- HaimeurAConseilGDeeleyRGColeSPThe MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulationCurr Drug Metab200451215314965249
- VarmaMVAsbokrajYDeyCSPanchagnulaRP-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancementPharm Res2003484347359
- MartinezMNAmidonGLA mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentalsJ Clin Pharmacol200242662064312043951
- CollnotEMBaldesCWempeMFMechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidityMol Pharm20074346547417367162
- FloreaBIThanouMJungingerHEBorchardGEnhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlationJ Control Release2006110235336116269199
- GottesmanMMFojoTBatesSEMultidrug resistance in cancer: role of ATP-dependent transportersNat Rev Cancer200221485811902585
- HoggardKMVarumKMIssaMImproved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomersGene Ther200411191441145215269712
- Sebolt-LeopoldJSHerreraRTargeting the mitogen-activated protein kinase cascade to treat cancerNat Rev Cancer200441293794715573115
- LaiWFLinMCNucleic acid delivery with chitosan and its derivativesJ Control Release2009134315816819100795